Oscar Health (OSCR) Stock May Be Undervalued On Current Earnings Power

Oscar Health has delivered a very strong multi year share price run, and the current level inevitably raises a simple question for investors. Is today’s price still grounded in what the insurer is earning, or has the story moved ahead of the underlying profits?

• Over the past 3 years the stock has returned about 4.3x, which puts a lot of weight on whether current earnings can support that kind of re-rating.
• The business model leans heavily on using technology and data to improve medical cost ratios, which can have a direct bearing on how much earnings power ultimately sits behind each US$1 of market value.
• The analysts covering Oscar Health have run their own numbers. See what analysts think Oscar Health's shares could be worth.

The issue now is whether Oscar Health’s current share price is adequately explained by what the company is earning today and what those earnings reasonably point to over time.

If you want to explore the same earnings-driven question you are considering for Oscar Health across a broader range of companies, review 34 high quality undervalued stocks.

Is Oscar Health Still Cheap on Earnings?

The P/E ratio matters for Oscar Health because earnings now exist to anchor the share price. The stock trades on roughly 18.2x, which is lower than both the wider insurance industry on about 11.3x and a peer group closer to 33.1x. That puts the company in an interesting middle ground, priced above the sector average but below many direct comparables that also lean on technology and data heavy models.

A tailored valuation framework that blends Oscar Health’s growth profile, profitability record, size and risk points to a higher P/E as a rough reference point than where the shares change hands today. On that basis the current multiple screens as undervalued relative to what that model suggests could be justified, leaving the question of whether you think the business can keep converting its data driven approach into durable earnings behind each US$1 of equity value. Explore the numbers behind Oscar Health's P/E valuation.

The Oscar Health Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the Oscar Health valuation puzzle leaves off by spelling out which paths for growth, margins and earnings would need to hold for the stock to be worth materially more or less than it is today on the Community page. Each narrative sets out a fair value as a clear, testable idea about Oscar Health's business so you can see how that view holds up as new information arrives.

Oscar Health attracts very different readings, with some investors seeing deep mispricing while others think expectations already bake in a lot.

Bull case: 94% undervalued

"The market is mispricing this asset by an order of magnitude…"

Discover why this Narrative puts Oscar Health at 94% undervalued.

Bear case: 7% overvalued

"Higher claims costs and evolving policy risks threaten profitability and future membership growth, despite efforts to reprice plans and leverage digital adoption trends…"

Explore why this Narrative puts Oscar Health at 7% overvalued.

One more piece of the Oscar Health puzzle before you act

Oscar Health’s share price and earnings get most of the attention, but the people steering the insurer and the way their rewards line up with your interests can tilt the whole risk and return profile. See who runs Oscar Health and how they are paid.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com